• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Innate and adaptive immunity in inflammatory bowel disease.炎症性肠病中的先天免疫和适应性免疫。
World J Gastroenterol. 2011 Jul 21;17(27):3178-83. doi: 10.3748/wjg.v17.i27.3178.
2
Immunopathogenesis of inflammatory bowel disease: current concepts.炎症性肠病的免疫发病机制:当前概念
Curr Opin Gastroenterol. 2007 Jul;23(4):365-9. doi: 10.1097/MOG.0b013e3281c55eb2.
3
Interactions between the host innate immune system and microbes in inflammatory bowel disease.宿主固有免疫系统与炎症性肠病中微生物的相互作用。
Gastroenterology. 2011 May;140(6):1729-37. doi: 10.1053/j.gastro.2011.02.012.
4
Evidence from genetics for a role of autophagy and innate immunity in IBD pathogenesis.遗传证据表明自噬和先天免疫在 IBD 发病机制中的作用。
Dig Dis. 2012;30(4):330-3. doi: 10.1159/000338119. Epub 2012 Jul 12.
5
New pathogenic paradigms in inflammatory bowel disease.炎症性肠病的新发病理学模式。
Inflamm Bowel Dis. 2012 Feb;18(2):368-71. doi: 10.1002/ibd.21735. Epub 2011 Apr 27.
6
The innate immune system and inflammatory bowel disease.先天性免疫系统与炎症性肠病。
Scand J Gastroenterol. 2015 Jan;50(1):24-33. doi: 10.3109/00365521.2014.966321.
7
Innate and adaptive immunity in inflammatory bowel disease.炎症性肠病中的先天免疫和适应性免疫。
Autoimmun Rev. 2014 Jan;13(1):3-10. doi: 10.1016/j.autrev.2013.06.004. Epub 2013 Jun 15.
8
Understanding inflammatory bowel disease via immunogenetics.通过免疫遗传学了解炎症性肠病。
J Autoimmun. 2015 Nov;64:91-100. doi: 10.1016/j.jaut.2015.07.013. Epub 2015 Aug 7.
9
Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.用于研究正常和炎症状态下人结肠上皮细胞代谢与免疫功能的体外模型的开发、验证及应用
Dan Med J. 2015 Jan;62(1):B4973.
10
Innate and adaptive immunity in inflammatory bowel diseases.炎症性肠病中的先天免疫和适应性免疫。
Dig Dis. 2013;31(3-4):317-20. doi: 10.1159/000354685. Epub 2013 Nov 14.

引用本文的文献

1
Vitamin D enhances the therapeutic effect of TNF-α antibodies through lipid metabolism in overweight IBD patients.维生素D通过超重炎症性肠病患者的脂质代谢增强肿瘤坏死因子-α抗体的治疗效果。
Cell Mol Life Sci. 2025 Apr 26;82(1):176. doi: 10.1007/s00018-025-05626-8.
2
Inflammatory Bowel Diseases and Non-Alcoholic Fatty Liver Disease: Piecing a Complex Puzzle Together.炎症性肠病与非酒精性脂肪性肝病:拼合复杂谜题
Int J Mol Sci. 2024 Mar 14;25(6):3278. doi: 10.3390/ijms25063278.
3
Hydrogen Regulates Ulcerative Colitis by Affecting the Intestinal Redox Environment.氢气通过影响肠道氧化还原环境来调节溃疡性结肠炎。
J Inflamm Res. 2024 Feb 12;17:933-945. doi: 10.2147/JIR.S445152. eCollection 2024.
4
Glycosides as Potential Medicinal Components for Ulcerative Colitis: A Review.糖苷类化合物作为溃疡性结肠炎潜在药用成分的研究进展。
Molecules. 2023 Jul 4;28(13):5210. doi: 10.3390/molecules28135210.
5
Therapeutic potential of mesenchymal stem/stromal cells (MSCs)-based cell therapy for inflammatory bowel diseases (IBD) therapy.间充质干细胞(MSCs)为基础的细胞疗法治疗炎症性肠病(IBD)的治疗潜力。
Eur J Med Res. 2023 Jan 27;28(1):47. doi: 10.1186/s40001-023-01008-7.
6
Malyngamide F Possesses Anti-Inflammatory and Antinociceptive Activity in Rat Models of Inflammation.马蔺酰胺 F 具有抗炎和抗伤害感受活性,可在炎症大鼠模型中发挥作用。
Pain Res Manag. 2021 Jun 18;2021:4919391. doi: 10.1155/2021/4919391. eCollection 2021.
7
Effects of probiotics on the enhancement of the innate mucosal immune response against pathogenic bacteria.益生菌对增强针对病原菌的先天性黏膜免疫反应的影响。
Iran J Microbiol. 2020 Oct;12(5):445-450. doi: 10.18502/ijm.v12i5.4606.
8
ROP16 ameliorated inflammatory bowel diseases inducing M2 phenotype of macrophages.ROP16 改善了诱导巨噬细胞 M2 表型的炎症性肠病。
World J Gastroenterol. 2019 Dec 7;25(45):6634-6652. doi: 10.3748/wjg.v25.i45.6634.
9
Adaptive Returns of Deficient Systemic Plasma Immunoglobulin G Levels as Rehabilitation Biomarker After Emergency Colectomy for Fulminant Ulcerative Colitis.暴发性溃疡性结肠炎急诊结肠切除术后,系统性血浆免疫球蛋白G水平不足的适应性恢复作为康复生物标志物
Clin Med Insights Gastroenterol. 2017 Dec 13;10:1179552217746692. doi: 10.1177/1179552217746692. eCollection 2017.
10
The PSMP-CCR2 interactions trigger monocyte/macrophage-dependent colitis.PSMP-CCR2 相互作用引发单核细胞/巨噬细胞依赖性结肠炎。
Sci Rep. 2017 Jul 11;7(1):5107. doi: 10.1038/s41598-017-05255-7.

本文引用的文献

1
Unraveling the genetics of autoimmunity.解析自身免疫性疾病的遗传学机制。
Cell. 2010 Mar 19;140(6):791-7. doi: 10.1016/j.cell.2010.03.003.
2
A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease.乌司奴单抗(一种人白细胞介素-12/23单克隆抗体)用于中重度克罗恩病患者的随机试验。
Gastroenterology. 2008 Oct;135(4):1130-41. doi: 10.1053/j.gastro.2008.07.014. Epub 2008 Jul 17.
3
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease.全基因组关联研究确定了30多个克罗恩病的不同易感基因座。
Nat Genet. 2008 Aug;40(8):955-62. doi: 10.1038/ng.175. Epub 2008 Jun 29.
4
IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity.免疫失调多内分泌病、肠病、X连锁综合征、叉头框蛋白3与调节性T细胞:自身免疫性疾病模型
Immunol Res. 2007;38(1-3):112-21. doi: 10.1007/s12026-007-0022-2.
5
Foxp3+ regulatory T cells: selfishness under scrutiny.Foxp3+调节性T细胞:受到审视的自私性
Immunity. 2007 Sep;27(3):417-9. doi: 10.1016/j.immuni.2007.08.008.
6
Unravelling the pathogenesis of inflammatory bowel disease.揭示炎症性肠病的发病机制。
Nature. 2007 Jul 26;448(7152):427-34. doi: 10.1038/nature06005.
7
IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways.白细胞介素-6通过促进白细胞介素-21和白细胞介素-23信号通路的顺序激活来调控辅助性T细胞17细胞的分化。
Nat Immunol. 2007 Sep;8(9):967-74. doi: 10.1038/ni1488. Epub 2007 Jun 20.
8
IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease.白细胞介素23受体变异决定炎症性肠病的易感性而非疾病表型。
Gastroenterology. 2007 May;132(5):1657-64. doi: 10.1053/j.gastro.2007.02.051. Epub 2007 Feb 24.
9
Foxp3 in control of the regulatory T cell lineage.Foxp3对调节性T细胞谱系的控制。
Nat Immunol. 2007 May;8(5):457-62. doi: 10.1038/ni1455.
10
IL-17 family cytokines and the expanding diversity of effector T cell lineages.白细胞介素-17家族细胞因子与效应T细胞谱系不断扩大的多样性。
Annu Rev Immunol. 2007;25:821-52. doi: 10.1146/annurev.immunol.25.022106.141557.

炎症性肠病中的先天免疫和适应性免疫。

Innate and adaptive immunity in inflammatory bowel disease.

机构信息

Medical Department I (Gastroenterology/Rheumatology/Infectious Diseases), Campus Benjamin Franklin, Charité Universitätsmedizin Berlin, Hindenburgdamm 30, 12203 Berlin, Germany.

出版信息

World J Gastroenterol. 2011 Jul 21;17(27):3178-83. doi: 10.3748/wjg.v17.i27.3178.

DOI:10.3748/wjg.v17.i27.3178
PMID:21912465
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3158392/
Abstract

Inflammatory bowel diseases are the consequence of a dysregulated mucosal immune system. The mucosal immune system consists of two arms, innate and adaptive immunity, that have been studied separately for a long time. Functional studies from in vivo models of intestinal inflammation as well as results from genome-wide association studies strongly suggest a cross-regulation of both arms. The present review will illustrate this interaction by selecting examples from innate immunity and adaptive immunity, and their direct impact on each other. Broadening our view by focusing on the cross-regulated areas of the mucosal immune system will not only facilitate our understanding of disease, but furthermore will allow identification of future therapeutic targets.

摘要

炎症性肠病是黏膜免疫系统失调的结果。黏膜免疫系统由先天免疫和适应性免疫两个分支组成,这两个分支长期以来一直被分开研究。来自肠道炎症的体内模型的功能研究以及全基因组关联研究的结果强烈提示这两个分支存在相互调节。本综述将通过选择先天免疫和适应性免疫及其相互直接影响的例子来说明这种相互作用。通过关注黏膜免疫系统的交叉调节区域来拓宽我们的视野,不仅将有助于我们对疾病的理解,而且还将有助于确定未来的治疗靶点。